Pharmaron Beijing Co., Ltd. convened an employee representative?s meeting on December 18, 2025, at which Mr. Li Shing Chung Gilbert was elected as the employee representative Director of the third session of the Board. His term of office shall commence on December 18, 2025 and shall end on the expiry of the term of the third session of the Board. Mr. Li, aged 47, is the chief financial officer and secretary of the Board.
He joined the Company in January 2008 as the financial controller and was appointed as the chief financial officer in January 2015. He was appointed as secretary of the Board in October 2016 and is primarily responsible for the overall financial function of the Company. In particular, he is responsible for the financing and M&A activities of the Group.
Mr. Li also serves as a supervisor or director at several subsidiaries of the Group. Prior to joining the Group, Mr. Li had served at various roles in accounting and financial areas. From 2000 to 2003, he served as assistant manager of KPMG.
Mr. Li obtained his bachelor?s degree in business administration from the Hong Kong University of Science and Technology in November 2000. Mr. Li obtained his master?s degree in business administration from the China Europe International Business School in July 2012. Mr. Li is a member of the Hong Kong Institute of Certified Public Accountants and the American Institute of Certified Public Accountants and a Chartered Financial Analyst.
Mr. Li is qualified to serve as the employee representative Director pursuant to the relevant provisions of the Company Law and the Articles of Association. Mr. Li has served as a director of Pharmaron Holdings Limited during the past five years.
